the role of enfortumab vedotin in earlier lines and stages of urothelial cancer | arjun balar
Published 3 years ago • 67 plays • Length 3:14Download video MP4
Download video MP3
Similar videos
-
1:06
treatment options for patients who progress on enfortumab vedotin | arjun balar
-
4:15
ev-201: enfortumab an option for cisplatin-ineligible advanced uc | arjun balar
-
1:18
the role of enfortumab vedotin in urothelial cancer treatment
-
2:58
ev-201: enfortumab vedotin for cisplatin-ineligible bladder cancer
-
34:39
bladder cancer and immunotherapy with dr. arjun balar
-
10:33
12 things i wish i knew before starting chemo | chemo tips; my 2nd cancer journey
-
18:36
breakthrough in bladder cancer: fda approval - enfortumab vedotin pelbrolizumab with dr.tom powles
-
13:09
tim after 30 rads & 2 cisplatin - hpv throat cancer
-
3:25
enfortumab vedotin with pembrolizumab for bladder cancer
-
6:39
induce-1 points to icos agonist activity in advanced urothelial cancer | arjun balar
-
47:59
advances in bladder cancer immunotherapy, with dr. arjun balar
-
1:50
dr. rosenberg discusses enfortumab vedotin in urothelial carcinoma
-
1:09
dr. balar on improved outlook in metastatic bladder cancer
-
2:09
enfortumab vedotin for bladder cancer
-
1:27
dr. sonpavde on enfortumab vedotin data in bladder cancer
-
1:32
dr. balar discusses study of immunotherapy combination in bladder cancer
-
2:03
dr. rosenberg on enfortumab vedotin/pembrolizumab in urothelial carcinoma
-
0:34
pembrolizumab plus enfortumab vedotin for bladder cancer
-
0:54
dr. balar on biomarkers of immunotherapy response in bladder cancer
-
27:26
advanced bladder cancer: dr. arjun balar talks treatment strategies in a changing field
-
40:58
urothelial carcinoma: advances in immuno-oncology
-
1:08
incorporating immunotherapy in the treatment of early-stage bladder cancer